RecruitingNot ApplicableNCT05842239

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia: a Pilot Study

Sponsor

Assaf-Harofeh Medical Center

Enrollment

15 participants

Start Date

Jan 20, 2024

Study Type

INTERVENTIONAL

Conditions

Oligospermia

Summary

Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.

Eligibility

Sex: MALEMin Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Hyperbaric oxygen therapy for people with oligospermia. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHyperbaric oxygen therapy

Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes

Locations(1)

The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)

Ẕerifin, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05842239

Related Trials

Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)

NCT073577012 locations

Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia

NCT062600071 location

Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®

NCT068698631 location